CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.48
Delayed Data
As of Mar 27
 +0.01 / +0.68%
Today’s Change
1.07
Today|||52-Week Range
2.09
+11.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization4.5K6.5K12.6K13.5K
 
 
 
 
 
 
Operating ExpensesGross Income-4.5K-6.5K-12.6K-13.5K
 
 
 
 
 
General Expenses1.3M1.4M1.6M1.8M
 
 
 
 
 
Research And Development612.6K560.0K724.5K697.0K
 
 
 
 
 
Total Operating Expenses1.3M1.5M1.6M1.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.3M-1.5M-1.6M-1.8M
 
 
 
 
 
Extraordinary Charge0.000.000.00-19.7M
 
 
Interest Expense On Debt0.000.000.003.5K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.3M-1.5M-1.6M-21.5M
 
 
 
 
 
Net Income-1.3M-1.5M-1.6M-21.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS27.0M27.0M27.0M27.8M
 
 
 
 
 
Shares To Calculate EPS Diluted27.0M27.0M27.0M27.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.05-$0.06-$0.77
 
 
 
 
 
EPS Diluted-$0.05-$0.05-$0.06-$0.77
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account